<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230723058896N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-09-09</date_registration>
      <primary_sponsor>Oroumia University of Medical Sciences</primary_sponsor>
      <public_title>Comparing the effect of GUIDED IMAGERY and CRYOTHERAPY(cold compress) on post operative pain severity and vital signs among laparoscopic cholecystectomy inpatients in Teaching Hospitals</public_title>
      <acronym>-</acronym>
      <scientific_title>Comparing the effect of GUIDED IMAGERY and CRYOTHERAPY(cold compress) on post operative pain severity and vital signs among laparoscopic cholecystectomy inpatients in Teaching Hospitals</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-09-11</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>93</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/71841</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Factorial, Purpose: Supportive, Randomization description: Simple randomization
The current study is a randomized controlled and one-sided blind trial with a sample size of 93 people in the form of three groups, 31 people in the guided imaging group with code one, 31 people in the cryotherapy group with code two, and 31 people in the control group with code three. In order to randomize, in a simple way, numbers from one to three are written on 93 sheets, and applicants who meet the entry criteria are asked to choose one of the numbers from one to three, and by choosing each number, the said number from It goes out between the sheets, Blinding description: The present study is a one blind study with a sample size of 93 people divided into three groups, 31 people in the guided imaging group with code one, 31 people in the cryotherapy group with code two, and 31 people in the control group with code three. In order to randomize, in a simple way, numbers one to three are written on 93 sheets, and applicants who meet the entry criteria are asked to choose one of the sheets , and by choosing each number, the said number is selected from among the sheets. It should be noted that none of the clients have any knowledge about the allocation of codes 1, 2 and 3 to the intervention and control groups and are completely blinded.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Laparoscopic cholecystectomy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In order to guided imagery , 20-minute voices or images will be used for this purpose under the supervision of a specialist consultant, according to the person's preference, which includes the sounds of the forest, sea, birds, fire and wind. Seekers in a calm and quiet environment. Voices or images. will receive through hands-free and pain intensity through the visual questionnaire of pain intensity (VAS) and vital signs by SAADAT brand portable monitor (calibrated and identical device) and to control the body temperature from the forehead area by infrared digital thermometer made in China The SK-30 INFRARED THERMOMETER model will be used and will be measured in 15-30-45-60 minutes. In addition to the mentioned times, we also measure the starting time (zero) of pain severity. Intervention 2: Intervention group: Patients receive cold therapy in the form of a cold compress in the temperature range of 15-18 degrees Celsius around the laparoscopic site for 20 minutes on a dressing that acts as a barrier to prevent direct contact and non-deep pressure, under the supervision of a specialist consultant, and in minutes 15-30-45-60 pain intensity is measured by (VAS) and vital signs by portable monitor and temperature by digital infrared thermometer. In addition to the mentioned times, we also measure the starting time (zero) of pain severity. Intervention 3: Control group: No intervention will be done in the control group.The intensity of pain in the patient after entering the department is measured 5 times - once immediately after entering the department and then in 15-30-45-60 minutes and vital signs are measured in 15-30-45-60 minutes and the collected data Demographic information will be recorded in the form for review and comparison. It should be noted that the client will receive treatment measures and painkillers if needed and with the order of the attending physician. The type and dose of painkillers received will be recorded in the demographic information form for review and comparison. During the entire study, the researcher will be present with all the patients of all three groups.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Shasaddin Shamsi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Urmia Nursing-Midwifery Faculty</address>
        <city>Urmia</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5756115335</zip>
        <telephone>+98 44 3275 4961</telephone>
        <email>shamsi_sh@umsu.ac.ir</email>
        <affiliation>Oroumia University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Shamsaddin Shamsi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Urmia Nursing-Midwifery Faculty</address>
        <city>Urmia</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5756115335</zip>
        <telephone>+98 44 3275 4961</telephone>
        <email>shamsi_sh@umsu.ac.ir</email>
        <affiliation>Oroumia University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Candidate for laparoscopic cholecystectomy surgery
Satisfaction and willingness to participate in the research
Age between 20-60 years old
Alertness after the operation
the disappearance of the effects of anesthetic drugs before the start of the intervention
Ability to use numerical scale of pain intensity
Having pain with a score greater than 3
No impairment in speech, hearing, vision and communication
Ability to speak Persian or Turkish
Do not have heart surgery or any cardiovascular disorder
Do not have a disease related to the prohibition of the use of cold, such as Raynaud's syndrome
No history of nerve diseases (neuropathy, muscle stiffness and poor blood circulation)
Any confirmed mental illness</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Unwillingness to participate and continue studying
Occurrence of physical problems and inability to continue the plan
Discharge of the patient by personal consent or death of the patient
Performing any procedure outside the routine schedule
Use of PCA pump</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K80.01</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Calculus of gallbladder with acute cholecystitis with obstruction</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Prevention</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In order to guided imagery , 20-minute voices or images will be used for this purpose under the supervision of a specialist consultant, according to the person's preference, which includes the sounds of the forest, sea, birds, fire and wind. Seekers in a calm and quiet environment. Voices or images. will receive through hands-free and pain intensity through the visual questionnaire of pain intensity (VAS) and vital signs by SAADAT brand portable monitor (calibrated and identical device) and to control the body temperature from the forehead area by infrared digital thermometer made in China The SK-30 INFRARED THERMOMETER model will be used and will be measured in 15-30-45-60 minutes. In addition to the mentioned times, we also measure the starting time (zero) of pain severity</i_keyword>
      <i_keyword>Intervention group: Patients receive cold therapy in the form of a cold compress in the temperature range of 15-18 degrees Celsius around the laparoscopic site for 20 minutes on a dressing that acts as a barrier to prevent direct contact and non-deep pressure, under the supervision of a specialist consultant, and in minutes 15-30-45-60 pain intensity is measured by (VAS) and vital signs by portable monitor and temperature by digital infrared thermometer. In addition to the mentioned times, we also measure the starting time (zero) of pain severity</i_keyword>
      <i_keyword>Control group: No intervention will be done in the control group.The intensity of pain in the patient after entering the department is measured 5 times - once immediately after entering the department and then in 15-30-45-60 minutes and vital signs are measured in 15-30-45-60 minutes and the collected data Demographic information will be recorded in the form for review and comparison. It should be noted that the client will receive treatment measures and painkillers if needed and with the order of the attending physician. The type and dose of painkillers received will be recorded in the demographic information form for review and comparison. During the entire study, the researcher will be present with all the patients of all three groups.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain severity. Timepoint: Before the start of the intervention (zero time) - 15-30-45-60 minutes. Method of measurement: Visual analogue scale questionnaire.</prim_outcome>
      <prim_outcome>Vital signs. Timepoint: 15-30-45-60 minutes. Method of measurement: Portable monitoring device and thermometer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Oroumia University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-02-01</approval_date>
        <contact_name>ethics committee of urmia medical university of science</contact_name>
        <contact_address>Research and Technology Vice-Chancellor, Building No. 10, West Azerbaijan University of Medical Sciences and Health Services, Jihad St., Resalat Blvd. Urmia West Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
